WeVote
Log In

Bill

Bill

HB 2160

RELATING TO CANCER.

2026 Regular Session Introduced by Terez Amato and 15 co-sponsors

Hawaii HB 2160 advances cancer-related policy through legislature with Health committee approval pending specified amendments to the bill's provisions.

Reported from HLT (Stand. Com. Rep. No. 157-26) as amended in HD 1, recommending passage on Second Reading and referral to HED.
#appropriation($) #capitalexpenditures #cigarettetax #debtservices #disposition #hawaiicancerresearchspecialfund #revenue #universityofhawaiicancercenter
0
WeVote Research Nonpartisan
Bill Summary · HB 2160

Legislative bill overview

HB 2160 is a Hawaii measure addressing cancer-related policy that has advanced through the Health committee with recommended amendments. The bill was referred to Health, Education, and Finance committees for consideration, indicating it likely involves healthcare delivery, funding, or educational components related to cancer prevention, treatment, or awareness.

Why is this important

Cancer prevention and treatment access directly affects public health outcomes and healthcare costs for Hawaii residents. Legislative action in this area can influence treatment availability, insurance coverage, screening programs, or workforce development in oncology services.

Potential points of contention

  • Fiscal impact unclear: The bill's referral to the Finance committee suggests budgetary implications that may create debate over funding priorities and state spending
  • Scope of amendments unknown: The Health committee's recommendation "with amendments" indicates substantive changes were made, but the specific modifications affecting the bill's intent are not detailed in available records
  • Implementation details: Without access to the bill's full text, the mechanism for cancer-related improvements (mandates, incentives, education, research funding) remains unclear and could generate disagreement among stakeholders

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.